Pro 2012-012 (Jianfeng Group's 2011 Annual Dividend Announcement)
Release time:
2020-08-05
Securities Code: 600668 Securities Abbreviation: Jianfeng Group Announcement No.: Lin 2012-012
Zhejiang Jianfeng Group Co., Ltd.
2011 Profit Distribution Implementation Announcement
The Company and all members of the Board of Directors guarantee that there are no false records, misleading statements or major omissions in the announcement, and assume individual and joint responsibility for the truthfulness, accuracy and completeness of its contents.
Important Note:
● Cash Dividend Per Share Before and After Tax Deduction
Units: yuan
cash dividend per share (before tax deduction) |
0.120 |
cash dividend per share (after tax deduction) |
0.108 |
● Equity registration date
Equity registration date |
June 29, 2012 |
● ex-rights (ex-dividend) date: july 2, 2012
● Cash Dividend Payment Date
Cash Dividend Payment Date |
July 6, 2012 |
1. passed the distribution and share capital increase scheme the 2011 profit distribution plan of Zhejiang jianfeng group co., ltd. was reviewed and approved by the 2011 shareholders' meeting held on may 8, 2012. The announcement of the resolution of the general meeting of shareholders was published in China Securities Journal, Shanghai Securities News and the website of Shanghai Stock Exchange on May 9, 2012.
2.
Distribution and Capital Transfer Plan(I)
Issuance Year: 2011(II)
Issuance Scope:After closing in Shanghai Stock Exchange on the afternoon of June 29, 2012, all shareholders of the Company registered in the Shanghai Branch of China Securities Depository and Clearing Corporation Limited.
(III)
This distribution is based on 344,083,828 shares, and a cash dividend of 1.2 yuan (tax included) will be distributed to all shareholders for every 10 shares, and a cash dividend of 1.08 yuan will be distributed for every 10 shares after tax deduction. The total dividend is 41,290,059.36 yuan.1.
Implementation Date(I)
Equity Registration Date(II)
Ex-Right (Ex-Dividend) Date: july 2, 2012(III)
Cash Dividend Payment Date2.
Distribution ObjectAfter the Shanghai Stock Exchange closes in the afternoon of June 29, 2012 (A-share equity registration date), all shareholders registered in the Shanghai Branch of China Securities Depository and Clearing Co., Ltd.
3.
Dividends and Capital Increases Implementation Measures1,
The cash dividends of Jinhua Tongji State-owned Assets Investment Co., Ltd., a shareholder of the Company, are directly distributed by the Company.2. The cash dividends of other shareholders of the company other than Jinhua Tongji State-owned Assets Investment Co., Ltd., the company entrusts China Securities Depository and Clearing Corporation Shanghai Branch to be distributed to the registered shareholders on the equity registration date through its capital clearing system. Investors who have handled comprehensive designated transactions can receive cash dividends at their designated securities business department on the dividend payment date. Shareholders' dividends that have not handled designated transactions are temporarily kept by the Shanghai Branch of China Securities Depository and Clearing Corporation, and will be distributed after the designated transactions are processed.
3. For the dividends of individual shareholders, qualified foreign institutional investors (QFII), and securities investment funds, the company will withhold and pay income tax at a tax rate of 10%, and the cash dividend after tax is 0.108 yuan per share. For the dividends of other institutional investors and corporate shareholders, they shall pay their own income tax, and the cash dividend is 0.12 yuan per share.
1.
Relevant Consultation Measures1, Address: Office of the Board of Directors of Jianfeng Building, 88 Wujiang East Road, Jinhua City, Zhejiang Province
2, Tel: 0579-82320582; Fax: 0579-231
Reference Document Catalogue
Resolutions and Announcements of the Company's 2011 Annual General Meeting of Shareholders.
Zhejiang Jianfeng Group Co., Ltd.
Date: June 26, 2012
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page